Aberrant presentation of autoantigens due to non-physiological release of PTX3 (13, 28, 57) could be involved, as indicated by the protective role of anti-PTX3 antibodies in SLE (58, 59). This evidence concerns the gene PTX3 and systemic lupus erythematosus.